Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Asterias Biotherapeutics, Inc. (ASTY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Asterias Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1572552.
Total stock buying since 2014: $4,233,026.
Total stock sales since 2014: $324,237.
Total stock option exercises since 2014: $29,250.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 23,291 | $39,983 | 0 | $0 | 0 | $0 |
| 2017 | 1,600,107 | $2,089,931 | 8,196 | $37,725 | 0 | $0 |
| 2016 | 2,245,764 | $593,969 | 54,792 | $217,200 | 12,500 | $29,250 |
| 2015 | 148,205 | $587,208 | 11,552 | $69,312 | 0 | $0 |
| 2014 | 185,000 | $921,935 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-08 | 3,141 | $5,000 | 0 | $0 | 0 | $0 |
| 2018-07 | 2,950 | $5,000 | 0 | $0 | 0 | $0 |
| 2018-06 | 3,067 | $4,999 | 0 | $0 | 0 | $0 |
| 2018-05 | 3,153 | $5,000 | 0 | $0 | 0 | $0 |
| 2018-04 | 3,752 | $4,990 | 0 | $0 | 0 | $0 |
| 2018-03 | 2,839 | $4,996 | 0 | $0 | 0 | $0 |
| 2018-02 | 2,255 | $4,999 | 0 | $0 | 0 | $0 |
| 2018-01 | 2,134 | $4,999 | 0 | $0 | 0 | $0 |
| 2017-12 | 2,247 | $4,988 | 0 | $0 | 0 | $0 |
| 2017-11 | 2,076 | $5,003 | 0 | $0 | 0 | $0 |
| 2017-10 | 1,594,247 | $2,074,944 | 0 | $0 | 0 | $0 |
| 2017-09 | 1,537 | $4,996 | 0 | $0 | 0 | $0 |
| 2017-01 | 0 | $0 | 8,196 | $37,725 | 0 | $0 |
| 2016-12 | 0 | $0 | 5,000 | $25,000 | 5,000 | $11,700 |
| 2016-11 | 0 | $0 | 7,500 | $38,525 | 7,500 | $17,550 |
| 2016-10 | 0 | $0 | 8,196 | $33,718 | 0 | $0 |
| 2016-09 | 0 | $0 | 34,096 | $119,957 | 0 | $0 |
| 2016-06 | 69,000 | $194,150 | 0 | $0 | 0 | $0 |
| 2016-05 | 2,176,764 | $399,819 | 0 | $0 | 0 | $0 |
| 2015-09 | 0 | $0 | 11,552 | $69,312 | 0 | $0 |
| 2015-06 | 20,000 | $87,209 | 0 | $0 | 0 | $0 |
| 2015-02 | 128,205 | $499,999 | 0 | $0 | 0 | $0 |
| 2014-10 | 50,000 | $298,350 | 0 | $0 | 0 | $0 |
| 2014-09 | 135,000 | $623,585 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-27 | Mulroy Michael H. (President and CEO) | Buy | 3,141 | 1.59 | 5,000 |
| 2018-07-25 | Mulroy Michael H. (President and CEO) | Buy | 2,950 | 1.70 | 5,000 |
| 2018-06-25 | Mulroy Michael H. (President and CEO) | Buy | 3,067 | 1.63 | 4,999 |
| 2018-05-25 | Mulroy Michael H. (President and CEO) | Buy | 3,153 | 1.59 | 5,000 |
| 2018-04-25 | Mulroy Michael H. (President and CEO) | Buy | 3,752 | 1.33 | 4,990 |
| 2018-03-26 | Mulroy Michael H. (President and CEO) | Buy | 2,839 | 1.76 | 4,996 |
| 2018-02-26 | Mulroy Michael H. (President and CEO) | Buy | 2,255 | 2.22 | 4,999 |
| 2018-01-25 | Mulroy Michael H. (President and CEO) | Buy | 2,134 | 2.34 | 4,999 |
| 2017-12-26 | Mulroy Michael H. (President and CEO) | Buy | 2,247 | 2.22 | 4,988 |
| 2017-11-27 | Mulroy Michael H. (President and CEO) | Buy | 2,076 | 2.41 | 5,003 |
| 2017-10-25 | Mulroy Michael H. (President and CEO) | Buy | 1,939 | 2.55 | 4,944 |
| 2017-10-16 | Bradsher Neal C | Buy | 1,592,308 | 1.30 | 2,070,000 |
| 2017-09-25 | Mulroy Michael H. (President and CEO) | Buy | 1,537 | 3.25 | 4,996 |
| 2017-01-09 | Wirth Edward (Chief Medical Officer) | Sale | 3,415 | 4.60 | 15,719 |
| 2017-01-09 | Spink Katharine E. (Chief Operating Officer) | Sale | 4,781 | 4.60 | 22,006 |
| 2016-12-27 | Wirth Edward (Chief Medical Officer) | Sale | 2,500 | 5.00 | 12,500 |
| 2016-12-27 | Wirth Edward (Chief Medical Officer) | Option Ex | 2,500 | 2.34 | 5,850 |
| 2016-12-27 | Spink Katharine E. (Chief Operating Officer) | Sale | 2,500 | 5.00 | 12,500 |
| 2016-12-27 | Spink Katharine E. (Chief Operating Officer) | Option Ex | 2,500 | 2.34 | 5,850 |
| 2016-11-23 | Spink Katharine E. (Chief Operating Officer) | Sale | 2,500 | 5.41 | 13,525 |
| 2016-11-23 | Spink Katharine E. (Chief Operating Officer) | Option Ex | 2,500 | 2.34 | 5,850 |
| 2016-11-17 | Wirth Edward (Chief Medical Officer) | Sale | 2,500 | 5.00 | 12,500 |
| 2016-11-17 | Wirth Edward (Chief Medical Officer) | Option Ex | 2,500 | 2.34 | 5,850 |
| 2016-11-17 | Spink Katharine E. (Chief Operating Officer) | Sale | 2,500 | 5.00 | 12,500 |
| 2016-11-17 | Spink Katharine E. (Chief Operating Officer) | Option Ex | 2,500 | 2.34 | 5,850 |
| 2016-10-06 | Wirth Edward (Chief Medical Officer) | Sale | 3,415 | 4.12 | 14,083 |
| 2016-10-06 | Spink Katharine E. (Chief Operating Officer) | Sale | 4,781 | 4.11 | 19,635 |
| 2016-09-09 | Wirth Edward (Chief Medical Officer) | Sale | 3,179 | 3.58 | 11,383 |
| 2016-09-09 | Spink Katharine E. (Chief Operating Officer) | Sale | 9,608 | 3.54 | 33,993 |
| 2016-09-08 | Wirth Edward (Chief Medical Officer) | Sale | 11,581 | 3.50 | 40,533 |
| 2016-09-08 | Spink Katharine E. (Chief Operating Officer) | Sale | 9,728 | 3.50 | 34,048 |
| 2016-06-30 | Cartt Stephen Lahue (President and CEO) | Buy | 10,000 | 2.40 | 23,980 |
| 2016-06-29 | Lebuhn Richard T. | Buy | 5,000 | 2.38 | 11,900 |
| 2016-06-10 | Cartt Stephen Lahue (President and CEO) | Buy | 50,000 | 2.93 | 146,550 |
| 2016-06-09 | Kingsley Alfred D | Buy | 4,000 | 2.93 | 11,720 |
| 2016-05-13 | Lebuhn Richard T. | Buy | 15,000 | 3.39 | 50,850 |
| 2016-05-13 | Broadwood Capital Inc | Buy | 2,058,823 | .00 | 0 |
| 2016-05-13 | Bailey Don M | Buy | 88,235 | 3.39 | 299,116 |
| 2016-05-13 | Ricciardi Natale S | Buy | 14,706 | 3.39 | 49,853 |
| 2015-09-15 | Wirth Edward (Chief Medical Officer) | Sale | 2,880 | 6.00 | 17,280 |
| 2015-09-15 | Spink Katharine E. (VP and Chief Operating Officer) | Sale | 3,760 | 6.00 | 22,560 |
| 2015-09-15 | Lebkowski Jane (President of R&D) | Sale | 4,912 | 6.00 | 29,472 |
| 2015-06-25 | Arno Andrew | Buy | 5,000 | 4.32 | 21,600 |
| 2015-06-25 | Lebuhn Richard T. | Buy | 5,000 | 4.41 | 22,060 |
| 2015-06-25 | Kingsley Alfred D | Buy | 5,000 | 4.32 | 21,575 |
| 2015-06-25 | Ricciardi Natale S | Buy | 5,000 | 4.39 | 21,974 |
| 2015-02-09 | Lichtinger Pedro (Chief Executive Officer) | Buy | 128,205 | 3.90 | 499,999 |
| 2014-10-01 | Scarsdale Equities Llc (Other) | Buy | 50,000 | 5.97 | 298,350 |
| 2014-09-29 | Scarsdale Equities Llc (Other) | Buy | 10,000 | 5.73 | 57,260 |
| 2014-09-24 | Scarsdale Equities Llc (10% Owner) | Buy | 10,000 | 5.35 | 53,540 |
| 2014-09-23 | Scarsdale Equities Llc (10% Owner) | Buy | 15,000 | 4.58 | 68,655 |
| 2014-09-05 | Scarsdale Equities Llc (10% Owner) | Buy | 30,000 | 5.48 | 164,340 |
| 2014-09-04 | Scarsdale Equities Llc (10% Owner) | Buy | 70,000 | 4.00 | 279,790 |
Insider trading activities including stock purchases, stock sales, and option exercises of ASTY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Asterias Biotherapeutics, Inc. (symbol ASTY, CIK number 1572552) see the Securities and Exchange Commission (SEC) website.